✦ LIBER ✦

Identification of a regulatory T cell subset that correlates with in vivo and in vitro immune responses in breast cancer patients receiving a CD4-eliciting, HER2 peptide vaccine (AE37)

✍ Scribed by Trappey, Alfred Francois; Berry, John S.; Mursal, Mohamed; Jama, Yusuf; Zacharia, Athina; Pham, Rebecca; Margulies, Eric; Ponniah, Sathibalan; Mittendorf, Elizabeth A.; Peoples, George E.

Book ID: 122960969
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 49 KB
Volume: 217
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2013.07.312

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Circulating regulatory T cells (CD4+CD25

Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide

✍ Jeremy D. Gates; Guy T. Clifton; Linda C. Benavides; Alan K. Sears; Mark G. Carm 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 479 KB

Levels of circulating regulatory CD4+CD2

Levels of circulating regulatory CD4+CD25+T cells are decreased in breast cancer patients after vaccination with a HER2/neupeptide (E75) and GM-CSF vaccine★

✍ Matthew T. Hueman; Alexander Stojadinovic; Catherine E. Storrer; Rebecca J. Fole 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 501 KB

Immunological monitoring of in vitro and

Immunological monitoring of in vitro and in vivo immune responses to the Ii-Key/HER2/neu MHC class II peptide vaccine in a phase I clinical trial in breast cancer patients

✍ S. Khoo; C.E. Storrer; K.A. Harris; Y.H. Jama; Z.A. Dehqanzada; C.D. Shriver; E. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB